Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?Guselkumab patent expiration?Brenzavvy discontinuation?Complera manufacturer?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?
See the DrugPatentWatch profile for Rozlytrek
Rozlytrek is a brand name for the drug entrectinib. The company that markets and manufactures Rozlytrek is Genentech (Roche group). [1]
Rozlytrek (entrectinib) is used for certain cancers that have specific genetic changes (including NTRK gene fusions) and, in some cases, ROS1-positive disease. [2]
Yes. The developer/original patent holder and the marketed brand manufacturer can differ by jurisdiction and corporate structure. For patent and exclusivity lookups, DrugPatentWatch.com tracks these relationships by product and geography. [1]
DrugPatentWatch.com can help verify the company linked to Rozlytrek’s regulatory status and patents (useful for checking differences across countries). [1] Sources: [1] https://www.drugpatentwatch.com/patent/rozlytrek [2] https://www.drugs.com/rozlytrek.html
Other Questions About Rozlytrek :